HIDES 1

 


 


 

Final results from HIDES phase 1
Presentation from EACS, Belgrade, October 2011


Other presentations from HIDES phase 1

Presentation from the HIV in the European Region Conference, Tallinn, May 2011

Presentation from the 10th International Congress on Drug Therapy in HIV Infection, Glasgow, November 2010, by Anders Sönnerborg

Enrollment by 15 June 2010


Presentation from the HIV in Europe 2009 Stockholm Conference, by Antonella D'Arminio Monforte


Introduction

The concept of indicator disease guided testing is an approach by which health care practitioners can be encouraged to test more patients based on suspicion of HIV. Little evidence on HIV prevalence exists for various conditions and diseases where HIV prevalence is thought to be higher than in the general population.

Objectives
The HIV in Europe pilot study assessed HIV prevalence in 8 indicator diseases in specific populations. The study included 17 centres in 14 countries and enrolled 7000 people presenting with an indicator disease.

Potential indicator diseases surveyed in the pilot phase:
Sexually Transmitted Diseases
Malignant Lymphoma
Cervical or anal dysplasia or cancer
Herpes Zoster
Hepatitis B or C virus infection
Ongoing mononucleosis-like illness
Leukocytopenia or thrombocytopenia
Seborrheic dermatitis / exanthema

Study Documents
Protocol
Analysis plan, May 2010

Newsletters
December 2009

Contact
For more information, please contact Project Coordinator:

Dorthe Raben
Rigshospitalet, University of Copenhagen
CHIP, Department of Infectious Diseases
Section 2100, Finsencentret
Blegdamsvej 9
DK-2100 Copenhagen Ø
Denmark
Tel: +45 35 45 57 82
Fax: +45 35 45 57 58
E-mail: dorthe.raben@regionh.dk